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PURPOSE. To demonstrate a new generation of three-dimen-
sional (3-D) ultrahigh-resolution optical coherence tomogra-
phy (UHR OCT) technology for visualization of macular dis-
eases.
METHODS. One hundred forty eyes with a distinct disease in
each of the posterior pole compartments were examined with
3-D UHR OCT. 3-D imaging was performed with a high axial
resolution of 3 m with a compact, commercially available,
ultra–broad-bandwidth (160 nm) titanium:sapphire laser at a
video rate of up to 25 B-scans/s. Each tomogram consisted of
1024  1024 pixels, resulting in 25 megavoxels/s.
RESULTS. 3-D UHR OCT offers high-precision 3-D visualization
of macular diseases at all structural levels. The UHR modality
allows identification of the contour of the hyaloid membrane,
tractive forces of epiretinal membranes, and changes within
the inner limiting membrane. The system provides quality 3-D
images of the topographic dynamics of traction lines from the
retinal surface down to the level of the photoreceptor seg-
ments. Intraretinal diseases are identified by their specific lo-
cation in different layers of the neurosensory ultrastructure.
Photoreceptor inner and outer segments are clearly delineated
in configuration and size, with a characteristic peak in the
subfoveal area. The microarchitecture of choroidal neovascu-
larization is distinctly imaged, related leakage can be identified,
and the volume can be quantified.
CONCLUSIONS. High-speed UHR OCT offers unprecedented, re-
alistic, 3-D imaging of ocular diseases at all epi-, intra- and
subretinal levels. A complete 3-D data set of the macular layers
allows a comprehensive analysis of focal and diffuse diseases,
as well as identification of dynamic pathomechanisms. (Invest
Ophthalmol Vis Sci. 2005;46:3393–3402) DOI:10.1167/iovs.05-
0370
Ultra–high-resolution optical coherence tomography (UHROCT)1–5 is a recently developed strategy that improves
established OCT technology6–8 and achieves unprecedented
in vivo visualization of subcellular features1 and retinal dis-
ease.2–5 UHR OCT exceeds standard-resolution OCT by obtain-
ing superior axial image resolution of 3 m compared with the
10- to 15-m threshold achieved so far in conventional retinal
imaging and therefore offers enhanced visualization of all in-
traretinal layers. Improved resolution and acquisition speed
allow, within 4 to 6 seconds, the performance of a noninvasive
optical biopsy of the human retina—that is, visualization of the
intraretinal morphology approaching a level of structural dif-
ferentiation obtainable only with histopathology. This quan-
tum leap in imaging performance is achieved by using a state of
the art ultra–broad-bandwidth light source instead of conven-
tional superluminescent diodes.
To evaluate the potential of UHR OCT for enhanced visual-
ization of intraretinal structures and to provide a distinct base
for correct interpretation of in vivo ophthalmic UHR OCT
tomograms, preclinical studies have been conducted to corre-
late UHR OCT cross-sectional images of in vivo porcine9 and
monkey10 (Macaca fascicularis) retinas with histologic sec-
tions of the identical specimen. The results of these compara-
tive studies allow extraction of structural information from in
vivo UHR ophthalmic OCT tomograms and substantially re-
duce the ambiguities in data interpretation. Analogies with
histologic features allow correlation of about 10 distinct in-
traretinal layers with corresponding signals in UHR OCT tomo-
grams. Recently, this novel OCT technology has been used in
a clinical setting for the first time, enabling in vivo cross-
sectional imaging of macular diseases with an unprecedented
axial resolution of 3 m, giving the technology unique value
in clinical imaging.4,11–13
In clinical practice, though, to detect early stage disease, to
follow disease progression, and to monitor therapy-induced
changes, it is best not to rely on a few B-scans (tomograms)
randomly taken at sites that are presumptively chosen during
image acquisition. An imaging modality, accomplishing UHR
visualization of all intraretinal layers within a few seconds
across a volume large enough to include the entire dimension
of the investigated disease would clearly have a significant
clinical impact on retinal diagnosis. With such a comprehen-
sive 3-D technique, the decision regarding a specific imaging
site would not have to be made during the process of data
acquisition. Instead, the complete 3-D data volume could ide-
ally be analyzed in more detail and at various locations after
image processing, similar to the procedures used in computed
tomography or magnetic resonance imaging.
First-generation, UHR OCT systems perform visualization of
the tissue microstructure in the so-called time domain. Depth
information in this case is obtained as a function of distance or
time. State of the art delay lines have been developed to
provide high scanning speeds of up to 8 kHz (i.e., 8000 A-scans
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per second14), with the drawback of lower system sensitivity
for faster scanning speed and/or broader optical bandwidth to
accomplish UHR and longer depth range. A potential alterna-
tive to time domain OCT for high-speed imaging is a technique
in which the entire spatially resolved tissue reflectance (A-
scan) is obtained simultaneously, and no depth scanning is
necessary.15–18 This technique has been referred to in the
literature as Fourier domain OCT, spectral domain OCT, fre-
quency domain OCT, and swept source OCT. The technical
improvement can be accomplished either by dispersing the
interferometric information in space by using a spectrometer
setup (also referred to as Fourier domain OCT or spectral
domain OCT in the literature) or by encoding information in
time by tuning a monochromatic light source in combination
with a single photodetector (also referred to in the literature as
frequency domain OCT or swept source OCT). The acquisition
speed for both approaches—using a spectrometer as a detec-
tor or a tuneable light source—is then mainly limited by the
read-out rate of the charge-coupled device (CCD) camera or
the tuning speed of the light source, respectively. Because of
the decoupling of scanning range and electronic detection
band width, both approaches offer a significant sensitivity
advantage, allowing a dramatic increase in line rate (A-scan
rate) without loosing imaging performance in comparison to
time domain OCT.19–21 Accordingly, OCT with a spectrometer
used for detection has recently been demonstrated to offer
high speed,22–24 UHR,25–27 and functional imaging.28,29
One possible approach to performing 3-D retinal imaging is
an extension of time domain OCT called en face OCT.30–34
This technique combines the transverse scanning approach of
a confocal scanning laser ophthalmoscope (cSLO) with the
depth-sectioning capabilities of OCT. This technique repre-
sents a cSLO with improved axial resolution by more than one
order of magnitude, allowing high transverse resolution en face
(also called C-mode scan) imaging. So far, 64 planes in depth,
each consisting of 256  128 pixels, enabling approximately 2
million voxels (3-D data points)/second, resulting in limited
cross-sectional (B-scan) visualization capability and a pixelized
tomogram appearance.
In this pilot study, we present the first clinical evaluation of
a second generation UHR OCT system with 3-D UHR OCT (3-D
UHR OCT), based on Fourier domain OCT, providing video
imaging of retinal diseases of all compartments (epiretinal,
intra-, subretinal) of the posterior pole of the eye.
METHODS
3-D UHR OCT Technology
3-D retinal imaging was performed with an axial resolution of 3 m
with a compact, commercially available ultra–broad-bandwidth (160
nm) titanium:sapphire laser (Integral; Femtolaser Produktions GmbH,
Vienna, Austria)35 at a video rate of up to 25 B-scans/s. Each tomogram
consisted of 1024 1024 pixels, resulting in 25 million voxels/s, more
than one order of magnitude better than existing en face OCT tech-
niques. Similar in vivo OCT sensitivity performance and visualization of
intraretinal layers, especially the inner (ISPR) and outer segment
(OSPR) of the photoreceptor layer, was achieved by 3-D UHR OCT
compared with standard UHR OCT, with a 100-fold higher data-acqui-
sition speed of 3-D UHR OCT, enabling unprecedented in vivo 3-D
ultrahigh resolution imaging of retinal diseases.
For the present study, the retinal exposure had to account for the
ultra–broad-bandwidth light generated by the laser. The ANSI stan-
dards36 for retinal exposure account for wavelength, exposure dura-
tion, and multiple exposures of the same spot of the retina. Because
the laser source generates femtosecond pulses, the laser output was
coupled into a 100-m-long optic fiber that was used to provide disper-
sive stretching of the pulse duration to hundreds of picoseconds. This
technique reduces the peak pulse intensities by several orders of
magnitude and, because the laser operates at an 80-MHz repetition
rate, the output can be handled as a continuous wave. OCT imaging
was performed with axial scans at rates ranging from 10,000 to 25,000
Hz, resulting in a retinal exposure time at each point where an axial
scan of 40 to 100 s was acquired. OCT imaging was performed with
800-W incident optical power in the scanning OCT beam, which is
well below the ANSI exposure limits. Each volume, acquired in 2.5 to
6 seconds (depending on the A-scan rate, which was chosen according
to the quality of the ocular media of the patients), consisted of 60
tomograms, each comprising 1024 A-scans moving in a transverse
direction with 1024 axial pixels, covering a diseased area of approxi-
mately 3  3 mm (except for the disease shown in Fig. 5, where 3 
5 mm was scanned and in Figs. 6A–E, where 2  3 mm was scanned),
at a depth of approximately 1 mm. With this incident power, a
sensitivity of 95 dB was achieved for all scanning conditions. The
sensitivity of the presented technique was measured with an artificial
eye consisting of a mirror and 25 mm of water in combination with a
neutral-density filter. With the same optical power and bandwidth as is
used in clinical in vivo measurements, the density of the optical filter
in front of the artificial eye was increased until a signal above the noise
could still be distinguished. The maximum of this signal was then used
in combination with the variance of the noise and the value of the
optical neutral-density filter to calculate the best sensitivity of the
system.
Patient Selection and Imaging Procedure
All investigations adhered to the tenets of the Declaration of Helsinki.
Written informed consent was obtained from all individuals in the
study after a detailed explanation of the nature and possible conse-
quences of the study procedures. The study was approved by the
Ethics Committee of the Medical University Vienna, School of Medi-
cine. All 3-D ultrahigh resolution OCT data in the present study were
acquired with 3-m axial and approximately 15- to 20-m transverse
resolution.
One hundred forty eyes with distinct macular diseases of different
origins and locations were included. The primary diagnosis was based
on a thorough clinical examination that included visual acuity testing,
slit lamp examination, and ophthalmoscopy. In cases demonstrating an
exudative component clinically, fluorescein angiography (FA) was
added to the diagnostic procedure. Eyes were grouped into diseases
with a primary epiretinal location including epiretinal membranes and
vitreomacular traction, with or without macular hole; an intraretinal
disease such as cystoid macular edema, central serous chorioretinopa-
thy, hereditary retinal disease; or an a priori subretinal location, such as
age-related macular degeneration with choroidal neovascularization
(CNV), dry changes such as drusen or atrophy of the retinal pigment
epithelium (RPE), or a serous detachment of the pigment epithelium
(PED).
RESULTS
3-D UHR OCT Imaging of the Physiologic
Macular Configuration
The retina within the macular region demonstrates a charac-
teristic 3-D appearance in 3-D UHR OCT imaging. Each 3-D
image consists currently of a series of 60 tomograms, each 3
mm in horizontal length, taken over a vertical distance of 3 mm
and an axial depth of 1 mm, resulting in a 3 3 1 mm optical
specimen. The serial presentation offers a comprehensive 3-D
view of the macular architecture (Fig. 1). Using a video-mode
movie technique, the specimen can be rotated around its axis
and can be viewed from different perspectives. The view from
the 6 o’clock position centered on the first tomographic sec-
tion at the specimen margin inferior to the fovea demonstrates
the contour of the retinal surface on top delineated by the
hyperreflectivity of the inner limiting membrane (ILM) and the
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nerve fiber layer (NFL) and the convex contour of the hyper-
reflective RPE/choroid band on the bottom. The retina at this
location appears relatively thick at a distance of approximately
1.5 mm apart from the foveal center (Fig. 1A). The retinal
surface in the subsequent section located behind this first
section is even more prominent, due to the radial distribution
of the NFL in the area of the concentric macular ring reflex. A
more transverse view of the 3-D UHR OCT specimen offers a
comprehensive view of the topography and morphology of the
entire foveal depression. The ILM/NFL bands of all 60 sections
form a smooth concavity in the center of the 3-D macular
specimen (Fig. 1B). Accordingly, a front view of the macular
surface produces an almost flat image of the macula, with a
dark round area in the center corresponding to the fovea (Fig.
1C). When the optical sample is further rotated during video
animation, the foveal depression is highlighted from the 12
o’clock perspective, superior to the fovea (Fig. 1D), which
completes the 3-D evaluation of a regular foveal contour in all
perspectives. The direct view on the last and uppermost to-
mographic section represents an upside-down perspective of
the macular specimen with the convex contour of the hyper-
reflective RPE-choroid band on top and the concave surface of
the ILM-NFL band on the bottom (Fig. 1E).
The direct view on the posterior pole of the RPE-choroid
curvature exhibits a comprehensive pattern of the retinal vas-
cular net consistent with an angiographic image, but without
the use of a fluorescent marker. The visualization of the vas-
culature is entirely due to the detection of the reflectance
shadows from the overlying vascular walls (Fig. 1F).
Analysis of Single UHR OCT Scans from
Serial Sections
Figure 2A demonstrates an OCT view of the fundus similar to
the one obtained by standard fundus photography, which can
be directly reproduced from 3-D UHR OCT data. This OCT
view is generated by summing the A-scan signal along the axial
direction, resulting in a brightness pixel value for each axial
scan, and can be used to register directly the UHR OCT tomo-
grams (Figs. 2C–E), in addition to a 3-D representation of the
imaged volume (Fig. 2B). Since each scan of the 60 sections
consists of 1024 A-scans with 1024 data points, a single tomo-
graphic scan can be extracted and analyzed separately to iden-
tify a specific site of interest. Even the architecture of the
normal macula varies substantially, depending on the precise
location and the distance from the foveal center. When tomo-
graphic images from the extrafoveal area, taken at a distance of
1 mm from the foveal center, are selected, the retinal band is
homogenous and wide, and no central thinning is seen (Fig.
2C). However, in the depth of the ganglion cell layer (GCL) and
inner plexiform layer (IPL) below the ILM/NFL, abundant areas
of focal hyperreflectivity are visible that originate from large-
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FIGURE 1. 3-D UHR OCT imaging of the physiologic macula (Movies 1, 2, http://www.iovs.org/cgi/content/full/46/9/3393/DC1). Different views
of a 3-D UHR OCT representation of a normal human fovea are depicted. The 3-D representation is constructed from of 60 tomograms, each
consisting of 1024 A-scans with 1024 sample points, covering an area of approximately 3  3  1 mm, acquired in approximately 4 to 5 seconds.
Comprehensive visualization of the topography and morphology of the entire foveal depression (A–E) and the pattern of the retinal vascular net
(F), consistent with an angiographic image, is demonstrated.
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diameter vessels such as arterioles and venules located on the
surface of the retina. The solid vascular walls produce distinct
zones of reflectance shadows throughout the underlying layers
(cf. Figs. 2C, 2D, red circles). Otherwise, the 10-layered struc-
ture of the retina appears as detailed as seen in conventional
two-dimensional (2-D) UHR OCT without any loss of axial
resolution. Approaching the juxtafoveal area, the center of the
tomogram section becomes thinner with the attenuation of the
nerve fiber density (Fig. 2D). Smaller-caliber blood vessels are
located deeper in the retina (i.e., within the inner nuclear layer
[INL]) and appear less hyperreflective with a narrower
shadow. The tomographic sections from the center of the
tomographic series, clearly delineate the central foveal depres-
sion (Fig. 2E). Retinal vessels and associated hyporeflective
shadows are completely absent. Characteristic features of the
central foveal area are an opacification of the ILM at the
deepest location (cf., Figs. 2F and 2G) of the depression,
consistent with a solid structural contact zone between the
posterior hyaloid membrane (not visualized), the ILM, and
Mu¨ller cells (not visualized) on the surface of the fovea and a
focal elevation of the external limiting membrane (ELM) and
the junctional band between the ISPR and OSPR on the bottom
of the foveal retina (cf. Figs. 2F and 2G). This prominence is
due to the increased length of the subfoveal cone outer seg-
ments in the foveal center, compared with the relatively
shorter OSPR in the extrafoveal retina.
Diseases of the Vitreomacular Interface
Diseases of the vitreomacular interface in the macular area may
exert traction in vertical as well as in axial direction and lead to
distortion of the retinal layers and loss of the foveal depression.
The alteration of the retinal surface is easily identified in the
appearance of the OCT fundus view (Fig. 3A) as well as in the
3-D overview of the UHR OCT tomography (Fig. 3B). Analysis
of the single scans in selected locations adds substantial infor-
mation regarding the distribution of the traction forces and the
resulting effects on the intraretinal organization. The single
scans clearly demonstrate the vertical direction of traction. A
horizontal epiretinal membrane leads to a fine overall wrin-
kling of the ILM surface. It is not apparent from the 3-D
overview image (Fig. 3B) that the thickened gliotic membrane
is attached in the nasal portion (right side), but is detached
from the temporal portion (left side; Figs. 3C, 3E) of the retina.
The contour of the posterior hyaloid membrane (cf. Figs. 3C
and 3E, white arrows) is visible in the detached left portion as
a continuation of the attached gliotic membrane on the right
and indicates that the disease originates from shrinkage of the
posterior hyaloidal membrane rather than from a separate
epiretinal membrane formation. The layered retinal architec-
ture is intact within the superficial portion of the retina, struc-
tural changes are distinctly located in the deep portion of the
retina beyond the outer nuclear layer (ONL; cf. areas indicated
by white arrows in Fig. 3D). In more superior scans, the
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FIGURE 2. Single UHR OCT tomograms from the 3-D UHR OCT data set (Movies 1, 2, http://www.iovs.org/cgi/content/full/46/9/3393/DC1). OCT
fundus view, generated from the UHR OCT A-scans (A) as well as 3-D UHR OCT overview (B; 3  3  1 mm) indicate the exact corresponding
location of the tomograms depicted in (C–E). Focal hyporeflectivity that originates from large-diameter vessels such as arterioles and venules (C, D,
red circles) and a clear increase of outer cone segments in the central foveal region are depicted, in addition to all other major intraretinal layers
(E–G). Rectangles: magnified views depicted in (F) and (G).
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epiretinal membrane is attached in a continuous connection
and without wrinkling to the ILM and NFL without significant
impact on the retinal layer integrity (Fig. 3D). The sensory
retina in the entire section is markedly thickened due to ver-
tical stretching. The foveal depression has disappeared com-
pletely, but the fovea can be identified by the characteristically
prominent OSPR region (Figs. 3D, 3E). The membrane is de-
tached from the foveal center and no signs of imminent hole
formation are present.
Intraretinal Diseases with Macular Hole
Vitreomacular traction in an axial direction leads to a com-
pletely different appearance of the 3-D ultrastructure of the
retina. Figure 4A depicts the OCT fundus view and indicates
the location of the extracted tomograms shown in Figures
4C–G. The 3-D overview illustrates a loss of the foveal contour
and a distinct central elevation of the retinal surface (Fig. 4B).
In the extrafoveal region, no traction is seen; however, cystic
changes are located in the superior portion of the retina,
mostly within the GCL and INL (Fig. 4C and twofold magnified
view in Fig. 4D). In the juxtafoveal area the localized attach-
ment of the posterior hyaloid membrane is clearly identified as
well as the resultant distortion of the intraretinal layers
throughout the entire thickness of the retina (Fig. 4E). The
foveolar site of focal traction on the ILM leads to a rupture of
the central retina with formation of a small, but full-thickness
macular hole (Fig. 4F). Superior to the fovea and outside of the
defect, the retina demonstrates massive cystic changes most
intensively within the deeper portion of the retina, including
the ONL and, to a lesser extent, within the superficial layers
(Fig. 4G).
Primary Disease of the RPE Layer
3-D UHR imaging of an eye with bull’s eye dystrophy demon-
strates characteristic pathognomonic features. Figure 5A de-
picts the OCT fundus view and indicates the location of the
extracted tomograms shown in Figures 5E–I. The surface to-
pography shows a round, irregular elevation of the perifoveal
retinal surface and a loss of the foveal depression (Fig. 5B). The
rotated side view of the optical specimen outlines significant
alterations of the intraretinal structures as well as two bandlike
extrusions of hyperreflectivity toward the choroid (Fig. 5C).
Further rotation, imaging the specimen from the choroid-RPE
side, shows that the hyperreflective bands form a characteristic
ring of hyperreflectance in the choroid (Fig. 5D). A single UHR
OCT scan (Fig. 5E) taken through the fovea demonstrates an
elevation with loss of RPE hyperreflectance ( phenomenon)
consistent with an absence of RPE pigmentation clinically (cf.
asterisks in Fig. 5F and images in Figs. 5C and 5D). Intraretinal
changes include a thinning of the ONL and an absence of the
ISPR and OSPR bands in areas of RPE loss (cf. Fig. 5F: Area of
intraretinal layer impairment is indicated by the red rectangle).
Superior to this site, two perifoveal areas of hyperreflectance
within the RPE band are detectable. However, below these
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FIGURE 3. Diseases of the vitreomacular interface: detachment and shrinkage of the posterior hyaloid membrane (Movies, 3, 4, http://www.iovs.
org/cgi/content/full/46/9/3393/DC1). OCT fundus view generated from the UHR OCT A-scans (A) and a 3-D UHR OCT overview (B; 3  3  1
mm) indicate the exact corresponding location of the tomograms depicted in (C–E). Clear visualization of overall wrinkling of the ILM surface and
the thickened gliotic hyaloid membrane is obtained (C, D). The membrane is detached from the foveal center and no signs of an imminent hole
formation are present (E). The posterior hyaloid membrane, indicated by two arrows, is shown in (C) and (E). (C–E) Distortion of the retinal
architecture is visible. (D, arrows): the ONL.
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areas, vertical bands of hyperreflectance allow better visualiza-
tion of choroidal structures, indicating a loss of integrity of the
RPE (Fig. 5G, and also 5C, 5D). Scans taken superior to the
fovea demonstrate similar changes in the intraretinal architec-
ture, including the loss of the junctional band between the
ISPR and OSPR bands (cf. Fig. 5I, arrows) The two hyperre-
flective elevations on the RPE band become confluent centrally
and intrachoroidal hyperreflective bands (e.g., asterisk in Fig.
5I) merge, creating the prominent choroidal ring pattern
( phenomenon) within the inferior curvature of the ring
structure visible in the rotated specimen (Figs. 5G, 5H, 5I and
also 5C, 5D).
Subretinal Disease with CNV
Subretinal diseases in age-related macular degeneration can
vary, even in the same patient, as documented in the following
images. Figure 6A depicts the OCT fundus view, covering the
area imaged by 3-D UHR OCT. There is a discrete central
swelling of the foveal retina. FA demonstrates active extrava-
sation from a subfoveal neovascular lesion (Fig. 6B). The loca-
tions of the 2-D scans shown in Figures 6C–E are indicated in
the OCT fundus view (Fig. 6A). 3-D UHR OCT outlines an
elevation of the central macular contour and single UHR scans
taken through the fovea (Figs. 6C–E) show the changes asso-
ciated with CNV. The foveal depression is reduced in depth,
but the retinal architecture is completely preserved up to the
ELM (Fig. 6C). Superior to the fovea, the focal detachment is
filled with serous fluid (Fig. 6C). The fluid is located under-
neath the partially interrupted junctional band between the
ISPRs and OSPRs, and the RPE band appears continuous. In the
next image, a focal irregularity is identified at the level of the
RPE and Bruch’s membrane (Fig. 6D). The full extent of RPE
and Bruch’s membrane erosion is seen in the foveal scan, were
the RPE band is absent in the center of the lesion and the
neovascular mass has grown through the entrance site and has
entered and filled the subretinal space (Fig. 6E).
The fellow eye (Figs. 6F–K) shows a central areolar atrophy,
clearly outlined by the OCT fundus view (Fig. 6F) as well as
indocyanine green angiography (ICGA; Fig. 6G). Correspond-
ing locations of the scans shown in Figures 6H–K are indicated
in the OCT fundus view (Fig. 6F). 3-D UHR OCT shows a
widened foveal depression of increased depth (Figs. 6H–K).
Outside the area of RPE atrophy, the retinal architecture is
completely preserved down to the photoreceptors and the RPE
band. However, there is a sudden change in the retinal struc-
ture overlaying the RPE atrophy. The junctional band between
the ISPRs and OSPRs is completely lost, as are the overlying
retinal structures up to about the IPL (cf. Fig. 6K, red arrows
indicating the intact band), a loss of the ELM (cf. Fig. 6K, white
arrows indicating the intact ELM), as well as a hyperreflectance
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FIGURE 4. Different stages of intraretinal diseases with vitreomacular traction and macular hole formation (Movies 5, 6, http://www.iovs.org/
cgi/content/full/46/9/3393/DC1). OCT fundus view, generated from the UHR OCT A-scans (A) and a 3-D UHR OCT overview (B; 3  3  1 mm)
indicate the exact corresponding location of the tomograms depicted in (C–G). 3-D overview illustrates a loss of the foveal contour and a distinct
central elevation of the retinal surface (B). In the extrafoveal region, no traction is visible; however, cystic changes are located in the GCL (C) and
the INL (G). (D) Twofold magnification of the area in the rectangle in (C), with the IPL (white arrows) and INL (red arrows) indicated. In the
juxtafoveal area, the localized attachment of the posterior hyaloid membrane is clearly identified as well as the resultant distortion of the intraretinal
layers throughout the entire thickness of the retina (E) finally resulting in the disruption of retinal integrity and the formation of a hole (F).
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window toward the choroids. Only proximal layers (e.g., the
GCL) seem relatively well preserved. Due to complete loss of
the RPE, consistent with a window defect, UHR OCT imaging
reaches deeper into the choroid because there is less absorp-
tion and scattering at the melanin-rich RPE layer.
DISCUSSION
A novel technology, 3-D ultrahigh resolution OCT, is presented
for the first time with its unique clinical potential. The tech-
nique allows the precise delineation of the surface configura-
tion of the macula (e.g., with thickening due to edema or
proliferative disease) and distortions of the retinal surface due
to vitreomacular traction or a loss in retinal substance in areas
of atrophy. 3-D imaging is more detailed than stereoscopic
ophthalmoscopy or photography, as it may be readily docu-
mented and quantified reproducibly. Animated video tech-
niques allow the rotation of the optical sample so that selected
features may be identified more clearly. The varying perspec-
tives allow the clinician to obtain a transparent “glass model” of
the retina with the pathologic changes highlighted by remod-
eling their contour and consistency. Based on such a compre-
hensive spatial overview, the dimension and volume of a dis-
ease may be measured and quantified in square millimeters.
The volumetric measurement offers realistic dimensions, be-
cause the 3-D sample is imaged by 60 or more parallel sections
and not extrapolated from six radial cuts only, with most of the
tissue area not covered by the imaging scan, which is the
technique used in conventional OCT mapping.7,8 Although 60
B-scans across an area of 3  3 or 3  5 mm have been used
in the present study, resulting in anisotropic 3-D sampling, it
was our intention to demonstrate that motion artifacts within
a B-scan are more significantly reduced with this technique.
Our second goal was to demonstrate that raster scanning of a
whole retinal volume—even in an anisotropic fashion—helps
the clinician to avoid missing any important retinal features in
the investigated area compared with effectiveness in that re-
gard of the state of the art, commercially available system.
Further developments in data acquisition technology will allow
3-D isotropic sampling of retinal volumes in the future.
In addition, the dynamic forces and distribution of distinct
diseases are monitored closely with reconstruction of traction
forces and identification of small, localized changes such as the
disruption of an epiretinal membrane, the focal break in the
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topography shows a round, irregular elevation of the perifoveal retinal surface and the loss of foveal depression (B), two bands for hyperreflectivity
within the choroid (C), and a characteristic ring of hyperreflectance in the choroidal overview (D). Single UHR OCT scans (E–I) taken through the
fovea imply thickening of the inner retinal layers, appearing as an inverse traction to the RPE-choroid. Also shown are intraretinal changes such
as thinning of the ONL and an absence of the ISPR and OSPR bands in areas of RPE loss (cf. F: area of intraretinal layer impairment is indicated
by the red rectangle as well as arrows in I). The two hyperreflective elevations on the RPE band become confluent centrally and intrachoroidal
hyperreflective bands (e.g., I, ✱) merged, creating a prominent choroidal ring pattern within the inferior curvature of the ring structure seen in
the rotated specimen (G–I and also C, D). (E, H, rectangles) Areas shown at higher magnification in (F) and (I).
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ILM membrane and hole operculum, or the penetration site of
the CNV through Bruch’s membrane. 3-D angiography is an-
other 3-D imaging method that provides a realistic representa-
tion of 3-D structural changes; however, it is restricted to the
identification of vascular structures only.37 The retinal thick-
ness analyzer (RTA) is limited to the detection of a surface
contour, the epiretinal ILM layer, and a deep contour, the
subretinal RPE layer, and does not provide any information
about structural changes between these two borders.
The second breakthrough in quality is the high 2-D resolu-
tion of the UHR technique which, after the comprehensive 3-D
representation, allows a detailed histologic sectioning of each
3-D site of interest. This feature permits insight into the in-
traretinal consequences of epiretinal traction from cystic
changes within the superficial layers down to misalignment of
the photoreceptor segments. A detailed scan-by-scan analysis
after data acquisition reveals undetected focal changes and
details of histologic changes, such as characteristics of macular
hole formation or neovascular growth. Diseases can be located
in relation to the intraretinal layer, and the primary site of
damage can be identified and is correlated to the overall 3-D
feature. Most important, the functional consequences of mac-
ular disease may be identified, with a precise representation of
the photoreceptor integrity and location of the foveola. Small
and early changes or changes outside the fovea do not escape
the imaging process. Details such as the morphologic differ-
ences between cysts with pseudohole formation and lamellar
macular holes are of substantial clinical relevance, and conven-
tional OCT allows only a rough differentiation between both
entities.38 Early stages of incomplete hole formation can easily
be detected in fellow eyes. Such formations may not be imaged
by conventional OCT, which is a major diagnostic problem.
The accidental orientation and location of the scan set by the
examiner has no influence on image quality or detection rate of
small lesions, as all sections may be screened retrospectively
and, with the high resolution used, any disease within the 3 
3- or 3  5-mm field is identified. A precise quantification of
lesions is also provided, such as the diameter and configuration
of a macular hole which is an important prognostic factor for
surgical intervention and influences the technique selected by
the surgeon.39 Chan et al.40 found a so-called stage 0 macular
hole in 28% of fellow eyes using advanced conventional OCT
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elevation of the central macular contour and show the changes associated with classic CNV. The CNV is located under the central partially
interrupted junctional band between the ISPR and the OSPR bands. Large parts of the CNV are above the RPE band, which is partially disrupted
(Movies 9, 10, http://www.iovs.org/cgi/content/full/46/9/3393/DC1: Please note that in 3-D Movie 9, the serous fluid of the CNV is visible to the
viewer in red in the retina). The fellow eye shows central areolar atrophy: OCT fundus view (F), ICGA (G) indicating (red square) scanned area.
Single scans illustrate sections with regular macular architecture (H), and the transitional zone with RPE attenuation and loss of retinal integrity
(I). The central UHR OCT scan (J) shows a widened foveal depression of increased depth, a complete loss of the ISPR and OSPR bands (cf. K, red
arrows: intact band), a loss of the ELM (cf. K, white arrows: intact ELM), as well as a hyperreflectance window toward the choroid. (J, rectangle)
Area shown at higher magnification in (K) (Movies 11, 12, http://www.iovs.org/cgi/content/full/46/9/3393/DC1: Both movies do not display the
whole retinal volume acquired, due to a strong motion artifact of the patient toward the end of the scan. This motion artifact does not affect the
OCT fundus image depicted in F).
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techniques. These stage 0 changes are defined as the presence
of a preretinal, minimally reflective, thin band inserting ob-
liquely on at least one side of the fovea.40 The topography of
such changes is not recognized by 2-D OCT alone, but is
identified with all its dynamics by 3-D UHR OCT. The improved
resolution of 2-D UHR OCT enables imaging of previously
unidentified changes in the photoreceptor morphology associ-
ated with macular hole and postoperative repair.11 3-D UHR
OCT allows identification of isolated or multiple focal changes
as well as their specific distribution throughout the macular
area. Visualization of the junction between the ISPR and OSPR
was shown to be an important indicator of photoreceptor
integrity.11 The level of photoreceptor disturbance clearly de-
termines the functional prognosis of any therapeutic interven-
tion, which becomes a major issue with emerging pharmaco-
logic interventions that have unknown end points of treatment
and carry significant costs. High-resolution 3-D OCT is the
appropriate noninvasive and precise modality to document the
value of selective modern strategies where conventional tech-
niques such as stereoscopic ophthalmoscopy and angiography
fail to identify ultrastructural changes and the mechanisms of
the therapeutical strategy. Novel pharmacologic modalities
(e.g., intravitreal steroids or antiangiogenic agents) avoid me-
chanical manipulation associated with earlier techniques, such
as surgery, laser coagulation, or photodynamic therapy, and
work by mechanisms that are neither completely understood
nor identified in their tissue interaction. Adequate diagnostic
modalities combining a solid stereoscopic evaluation of the
treatment effect and a detailed focal resolution of the ultra-
structural mechanisms are urgently needed. 3-D UHR OCT
characteristics perfectly fulfill this requirement and will allow
the clinical development of these new strategies to proceed.
3-D UHR OCT enables unprecedented visualization of all
major intraretinal layers, which had previously been possible
only with histopathology. Clear visualization of all the major
intraretinal layers and the ability to assess changes of retinal
morphology associated with retinal diseases in an early stage,
especially in the ISPR-OSPR/ELM/RPE complex, promises to
have a significant impact on diagnosis and investigation and to
provide a better understanding of pathogenesis and evaluation
of novel therapy approaches for a variety of macular diseases.
The hypothesis is that intraretinal structures that are relevant
for the diagnosis and monitoring of early stages of eye diseases
can be resolved by the proposed optical biopsy version of 3-D
UHR OCT.
It is unlikely that OCT will replace histology or other exist-
ing ophthalmic diagnostic modalities. However, from the view-
point of screening and diagnosis of diseases, the proposed
version of OCT may enable significantly new insight into the
pathogenesis and therapeutic control of several retinal dis-
eases. The unique features of this developed technology would
enable a broad range of research and clinical applications,
which may not only complement many of the existing oph-
thalmic imaging technologies available today, but also may
reveal previously unseen intraretinal changes.
This quantum leap in imaging performance is achieved by
with a state of the art ultra–broad-bandwidth light source
instead of superluminescent diodes. The ultimate availability of
this UHR OCT technology strongly depends on the availability
of ultra–broad-bandwidth light sources that are suitable for
OCT applications.
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